JP2010511631A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010511631A5 JP2010511631A5 JP2009539526A JP2009539526A JP2010511631A5 JP 2010511631 A5 JP2010511631 A5 JP 2010511631A5 JP 2009539526 A JP2009539526 A JP 2009539526A JP 2009539526 A JP2009539526 A JP 2009539526A JP 2010511631 A5 JP2010511631 A5 JP 2010511631A5
- Authority
- JP
- Japan
- Prior art keywords
- oxo
- methyl
- hydrazino
- ylidene
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 11
- 239000008194 pharmaceutical composition Substances 0.000 claims 9
- 239000000546 pharmaceutical excipient Substances 0.000 claims 9
- 102100039064 Interleukin-3 Human genes 0.000 claims 3
- 108010002386 Interleukin-3 Proteins 0.000 claims 3
- 239000003246 corticosteroid Substances 0.000 claims 3
- 150000002148 esters Chemical class 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000012453 solvate Substances 0.000 claims 3
- -1 3,4-dimethylphenyl Chemical group 0.000 claims 2
- HUXRZBPLHCQNJG-UHFFFAOYSA-N CC1=NN(C=2C=CC(=CC=2)C(C)(C)C)C(=O)C1=NNC(C=1O)=CC=CC=1C1CCCC(C(O)=O)C1 Chemical compound CC1=NN(C=2C=CC(=CC=2)C(C)(C)C)C(=O)C1=NNC(C=1O)=CC=CC=1C1CCCC(C(O)=O)C1 HUXRZBPLHCQNJG-UHFFFAOYSA-N 0.000 claims 2
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 claims 2
- MDEYDJMBBYPWIW-UHFFFAOYSA-N CC1=NN(C=2C=C(C)C(C)=CC=2)C(=O)C1=NNC(C=1O)=CC=CC=1C(C1)CCCC1C1=NN=NN1 Chemical compound CC1=NN(C=2C=C(C)C(C)=CC=2)C(=O)C1=NNC(C=1O)=CC=CC=1C(C1)CCCC1C1=NN=NN1 MDEYDJMBBYPWIW-UHFFFAOYSA-N 0.000 claims 1
- NMYJEIYTPHABEP-UHFFFAOYSA-N CC1=NN(C=2C=C(C)C(C)=CC=2)C(=O)C1=NNC(C=1O)=CC=CC=1C1CCCC(C(O)=O)C1 Chemical compound CC1=NN(C=2C=C(C)C(C)=CC=2)C(=O)C1=NNC(C=1O)=CC=CC=1C1CCCC(C(O)=O)C1 NMYJEIYTPHABEP-UHFFFAOYSA-N 0.000 claims 1
- ZSBUXAXZIIWTBH-UHFFFAOYSA-N CC1=NN(C=2C=C(C)C(C)=CC=2)C(=O)C1=NNC(C=1O)=CC=CC=1C1CCN(CC(O)=O)CC1 Chemical compound CC1=NN(C=2C=C(C)C(C)=CC=2)C(=O)C1=NNC(C=1O)=CC=CC=1C1CCN(CC(O)=O)CC1 ZSBUXAXZIIWTBH-UHFFFAOYSA-N 0.000 claims 1
- QYPGHFAIQBEDQV-UHFFFAOYSA-N O=C1C(=NNC=2C(=C(C3CC(CCC3)C(O)=O)C=CC=2)O)C(C)=NN1C1CCP(C)(=O)CC1 Chemical compound O=C1C(=NNC=2C(=C(C3CC(CCC3)C(O)=O)C=CC=2)O)C(C)=NN1C1CCP(C)(=O)CC1 QYPGHFAIQBEDQV-UHFFFAOYSA-N 0.000 claims 1
- OVPKUCGXERLTIC-UHFFFAOYSA-N O=C1C(=NNC=2C(=C(C3CC(CCC3)C=3NN=NN=3)C=CC=2)O)C(C)=NN1C(CC1)CCN1C1CC1 Chemical compound O=C1C(=NNC=2C(=C(C3CC(CCC3)C=3NN=NN=3)C=CC=2)O)C(C)=NN1C(CC1)CCN1C1CC1 OVPKUCGXERLTIC-UHFFFAOYSA-N 0.000 claims 1
- NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86196306P | 2006-12-01 | 2006-12-01 | |
| PCT/US2007/086186 WO2008070583A2 (en) | 2006-12-01 | 2007-11-30 | Thrombopoietin mimetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010511631A JP2010511631A (ja) | 2010-04-15 |
| JP2010511631A5 true JP2010511631A5 (enExample) | 2011-01-27 |
Family
ID=39493014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009539526A Pending JP2010511631A (ja) | 2006-12-01 | 2007-11-30 | トロンボポエチン擬態物 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7786159B2 (enExample) |
| EP (1) | EP2086551A4 (enExample) |
| JP (1) | JP2010511631A (enExample) |
| AU (1) | AU2007329464A1 (enExample) |
| CA (1) | CA2670345A1 (enExample) |
| WO (1) | WO2008070583A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CY2010012I2 (el) * | 2000-05-25 | 2020-05-29 | Novartis Ag | Μιμητικα θρομβοποιητινης |
| WO2008070583A2 (en) * | 2006-12-01 | 2008-06-12 | Stategics, Inc. | Thrombopoietin mimetics |
| US8476249B2 (en) | 2009-05-07 | 2013-07-02 | Glaxosmithkline Llc | Method of treating thrombocytopenia |
| EP2427053A4 (en) * | 2009-05-07 | 2012-12-05 | Glaxosmithkline Llc | METHOD FOR TREATING THROMBOCYTOPENIA |
| CN101921232A (zh) * | 2009-06-11 | 2010-12-22 | 上海恒瑞医药有限公司 | 双环取代吡唑酮偶氮类衍生物的盐,其制备方法及其在医药上的应用 |
| WO2012121958A2 (en) * | 2011-03-08 | 2012-09-13 | Glaxosmithkline Llc | Combination |
| WO2013072921A2 (en) * | 2011-09-13 | 2013-05-23 | Glenmark Generics Limited | Process for preparation of substituted 3'-hydrazino-biphenyl-3-carboxylic acid compounds |
| US9492430B2 (en) | 2011-11-14 | 2016-11-15 | Ligand Pharmaceuticals, Incorporated | Methods and compositions associated with the granulocyte colony-stimulating factor receptor |
| JP6150374B2 (ja) * | 2012-11-15 | 2017-06-21 | 国立大学法人弘前大学 | 放射線被ばく治療剤及び放射線被ばく治療方法 |
| US9962370B2 (en) | 2013-03-15 | 2018-05-08 | Ligand Pharmaceuticals Incorporated | Methods of treatment associated with the granulocyte colony-stimulating factor receptor |
| CN104257928A (zh) * | 2014-10-20 | 2015-01-07 | 王艳萍 | 一种治疗软组织损伤疼痛综合症的中药制剂 |
| BR112020001367A2 (pt) | 2017-07-26 | 2020-08-11 | Janssen Pharmaceutica N.V. | métodos de proteção da integridade vascular induzida por terapia de radiação direcionada |
| WO2020154585A1 (en) * | 2019-01-25 | 2020-07-30 | Janssen Pharmaceutica Nv | Methods for mitigating liver injury and promoting liver hypertrophy, regeneration and cell engraftment in conjunction with radiation and/or radiomimetic treatments |
| WO2024249284A2 (en) * | 2023-05-26 | 2024-12-05 | Ipsen Pharma S.A.S. | Bax activators and use thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3141772A (en) * | 1963-08-09 | 1964-07-21 | Polaroid Corp | Photographic products, processes and compositions employing azo dye developers |
| BE634840A (enExample) * | 1961-08-10 | |||
| DE1182432B (de) * | 1962-04-26 | 1964-11-26 | Basf Ag | Verfahren zur Herstellung von thermoplastischen farbigen makromolekularen Stoffen |
| US3666746A (en) * | 1969-06-25 | 1972-05-30 | Gaf Corp | Pyrrolidonylphenyl azo dyestuffs |
| US5132189A (en) * | 1989-09-07 | 1992-07-21 | Fuji Electric Co., Ltd. | Photoconductor for electrophotography |
| JPH04128767A (ja) * | 1990-09-19 | 1992-04-30 | Fuji Electric Co Ltd | 電子写真用感光体 |
| EP1125990A4 (en) * | 1999-07-29 | 2002-10-09 | Mitsui Chemicals Inc | YELLOW COMPOUND, AND WATER-CONTENT JET PRINTING INK COMPRISING THE COMPOUND |
| WO2001017349A1 (en) * | 1999-09-10 | 2001-03-15 | Smithkline Beckman Corporation | Thrombopoietin mimetics |
| CY2010012I2 (el) | 2000-05-25 | 2020-05-29 | Novartis Ag | Μιμητικα θρομβοποιητινης |
| WO2003103686A1 (en) | 2002-06-06 | 2003-12-18 | Smithkline Beecham Corporation | Thrombopoietin mimetics |
| WO2005118551A2 (en) | 2004-05-28 | 2005-12-15 | Ligand Pharmaceuticals Inc. | Thrombopoietin activity modulating compounds and methods |
| MX2007004765A (es) * | 2004-10-25 | 2007-07-09 | Ligand Pharm Inc | Compuestos y metodos que modulan la actividad de la trombopoyetina. |
| US7226575B2 (en) * | 2004-11-30 | 2007-06-05 | Chevron U.S.A. Inc. | Boron-containing molecular sieve CHA |
| WO2007062078A2 (en) * | 2005-11-23 | 2007-05-31 | Ligand Pharmaceuticals Inc. | Thrombopoietin activity modulating compounds and methods |
| BRPI0621027A2 (pt) | 2006-01-13 | 2011-11-29 | Pharmacyclics Inc | composto, composição farmacêutica |
| WO2008070583A2 (en) | 2006-12-01 | 2008-06-12 | Stategics, Inc. | Thrombopoietin mimetics |
-
2007
- 2007-11-30 WO PCT/US2007/086186 patent/WO2008070583A2/en not_active Ceased
- 2007-11-30 AU AU2007329464A patent/AU2007329464A1/en not_active Abandoned
- 2007-11-30 JP JP2009539526A patent/JP2010511631A/ja active Pending
- 2007-11-30 US US11/948,955 patent/US7786159B2/en not_active Expired - Fee Related
- 2007-11-30 EP EP07865054A patent/EP2086551A4/en not_active Withdrawn
- 2007-11-30 CA CA002670345A patent/CA2670345A1/en not_active Abandoned
-
2010
- 2010-08-10 US US12/853,800 patent/US8143287B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012533546A5 (enExample) | ||
| JP2008201787A5 (enExample) | ||
| JP2010536766A5 (enExample) | ||
| JP2011524850A5 (enExample) | ||
| JP2011529054A5 (enExample) | ||
| JP2014515013A5 (enExample) | ||
| JP2010513478A5 (enExample) | ||
| CO6612204A2 (es) | Nuevas composiciones de 1-(2(2.4 dimetil-fenilsulfanil)- fenil) piperazina | |
| WO2007096151A3 (en) | Inhibitors of p38-kinase for treatment of pulmonary hypertension | |
| JP2010077141A5 (enExample) | ||
| MX2010004501A (es) | Inhibidor de la proteina de activacion de 5-lipoxigenasa (plap). | |
| JP2007508360A5 (enExample) | ||
| JP2006514611A5 (enExample) | ||
| JP2009538276A5 (enExample) | ||
| JP2012508734A5 (enExample) | ||
| JP2012507535A5 (enExample) | ||
| JP2006501306A5 (enExample) | ||
| CN115803328A (zh) | 哌嗪-2,3-二酮衍生物及其在医药上的应用 | |
| JP2011517697A5 (enExample) | ||
| JP2013506674A5 (enExample) | ||
| JP2008534558A5 (enExample) | ||
| JP2020097577A5 (enExample) | ||
| JP2011500575A5 (enExample) | ||
| JP2009040767A5 (enExample) | ||
| JP2012501334A5 (enExample) |